FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

36603811000001107: Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112460001000001115 Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112460101000001119 Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Is a Beclometasone 250micrograms/actuation inhaler CFC free true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has active ingredient Beclometasone true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Beclometasone dipropionate true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Is a Soprobec true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has AMP True Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start